These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17000697)

  • 21. Evaluation of death pathway genes FAS and FASL polymorphisms in chronic HBV infection.
    Zamani AG; Barlas IO; Durakbasi-Dursun G; Ural O; Erdal E; Yildirim MS
    Int J Immunogenet; 2013 Dec; 40(6):482-7. PubMed ID: 23560484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer.
    Zhang B; Sun T; Xue L; Han X; Zhang B; Lu N; Shi Y; Tan W; Zhou Y; Zhao D; Zhang X; Guo Y; Lin D
    Carcinogenesis; 2007 May; 28(5):1067-73. PubMed ID: 17183065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Importance of FAS-1377, FAS-670, and FASL-844 polymorphisms in tumor onset, progression, and pigment phenotypes of Swedish patients with melanoma: a case-control analysis.
    Zhang H; Sun XF; Synnerstad I; Rosdahl I
    Cancer J; 2007; 13(4):233-7. PubMed ID: 17762757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers.
    Ji X; Neumann AS; Sturgis EM; Adler-Storthz K; Dahlstrom KR; Schiller JT; Wei Q; Li G
    Carcinogenesis; 2008 Apr; 29(4):875-9. PubMed ID: 18258602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional polymorphisms in cell death pathway genes FAS and FAS ligand and risk of alopecia areata.
    Kalkan G; Ateş O; Karakuş N; Sezer S
    Arch Dermatol Res; 2013 Dec; 305(10):909-15. PubMed ID: 23591741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caspase 9 promoter polymorphisms and risk of primary lung cancer.
    Park JY; Park JM; Jang JS; Choi JE; Kim KM; Cha SI; Kim CH; Kang YM; Lee WK; Kam S; Park RW; Kim IS; Lee JT; Jung TH
    Hum Mol Genet; 2006 Jun; 15(12):1963-71. PubMed ID: 16687442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic polymorphisms of IL-1A, IL-1B, IL-1RN, NFKB1, FAS, and FASL, and risk of silicosis in a Chinese occupational population.
    Wu F; Xia Z; Qu Y; Tang Y; Cao D; Sun P; Christiani DC
    Am J Ind Med; 2008 Nov; 51(11):843-51. PubMed ID: 18666137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphisms in the apoptosis-associated genes FAS and FASL and risk of oral cancer and malignant potential of oral premalignant lesions in a Taiwanese population.
    Wang LH; Ting SC; Chen CH; Tsai CC; Lung O; Liu TC; Lee CW; Wang YY; Tsai CL; Lin YC
    J Oral Pathol Med; 2010 Feb; 39(2):155-61. PubMed ID: 20359312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic polymorphisms in the tobacco smoke carcinogens detoxifying enzyme UGT1A7 and the risk of head and neck cancer.
    Lacko M; Roelofs HM; te Morsche RH; Voogd AC; Ophuis MB; Peters WH; Manni JJ
    Head Neck; 2009 Oct; 31(10):1274-81. PubMed ID: 19360737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced repair of the oxidative 8-oxoguanine DNA damage and risk of head and neck cancer.
    Paz-Elizur T; Ben-Yosef R; Elinger D; Vexler A; Krupsky M; Berrebi A; Shani A; Schechtman E; Freedman L; Livneh Z
    Cancer Res; 2006 Dec; 66(24):11683-9. PubMed ID: 17178863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.
    Singh M; Shah PP; Singh AP; Ruwali M; Mathur N; Pant MC; Parmar D
    Mutat Res; 2008 Feb; 638(1-2):184-94. PubMed ID: 18035380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of FAS -1377 G>A and FAS -670 A>G functional polymorphisms of FAS gene of cell death pathway with recurrent early pregnancy loss risk.
    Nair RR; Khanna A; Singh K
    J Reprod Immunol; 2012 Mar; 93(2):114-8. PubMed ID: 22386066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet 12-lipoxygenase Arg261Gln polymorphism: functional characterization and association with risk of esophageal squamous cell carcinoma in combination with COX-2 polymorphisms.
    Guo Y; Zhang X; Tan W; Miao X; Sun T; Zhao D; Lin D
    Pharmacogenet Genomics; 2007 Mar; 17(3):197-205. PubMed ID: 17460548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutagen sensitivity to benzo(a)pyrene diol epoxide and the risk of squamous cell carcinoma of the head and neck.
    Wang LE; Sturgis EM; Eicher SA; Spitz MR; Hong WK; Wei Q
    Clin Cancer Res; 1998 Jul; 4(7):1773-8. PubMed ID: 9676854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy.
    Zanone Poma B; Riva A; Nasi M; Cicconi P; Broggini V; Lepri AC; Mologni D; Mazzotta F; Monforte AD; Mussini C; Cossarizza A; Galli M;
    AIDS; 2008 Sep; 22(14):1769-78. PubMed ID: 18753860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption.
    Werbrouck J; De Ruyck K; Duprez F; Van Eijkeren M; Rietzschel E; Bekaert S; Vral A; De Neve W; Thierens H
    Mutat Res; 2008 Oct; 656(1-2):74-81. PubMed ID: 18768166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glutathione S-transferase polymorphisms and the synergy of alcohol and tobacco in oral, pharyngeal, and laryngeal carcinoma.
    Peters ES; McClean MD; Marsit CJ; Luckett B; Kelsey KT
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2196-202. PubMed ID: 17119046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of nucleotide excision repair proteins in lymphocytes as a marker of susceptibility to squamous cell carcinomas of the head and neck.
    Wei Q; Wang LE; Sturgis EM; Mao L
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1961-6. PubMed ID: 16103444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylenetetrahydrofolate reductase polymorphisms and risk of squamous cell carcinoma of the head and neck: a case-control analysis.
    Neumann AS; Lyons HJ; Shen H; Liu Z; Shi Q; Sturgis EM; Shete S; Spitz MR; El-Naggar A; Hong WK; Wei Q
    Int J Cancer; 2005 May; 115(1):131-6. PubMed ID: 15688408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of Fas (CD95) and FasL (CD178) polymorphisms in liver transplant recipients.
    Marín LA; Muro M; Moya-Quiles MR; Miras M; Minguela A; Bermejo J; Sanchez-Bueno F; Parrilla P; Alvarez-López MR
    Tissue Antigens; 2006 Feb; 67(2):117-26. PubMed ID: 16441482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.